Rachel R Deer1,2, Jared M Dickinson1,3, Jacques Baillargeon4, Steven R Fisher1,5, Mukaila Raji1,6, Elena Volpi1,6. 1. Sealy Center on Aging, The University of Texas Medical Branch, Galveston. 2. Division of Rehabilitation Sciences, The University of Texas Medical Branch, Galveston. 3. School of Nutrition and Health Promotion, Healthy Lifestyles Research Center, Arizona State University, Phoenix. 4. Department of Preventive Medicine and Community Health, The University of Texas Medical Branch, Galveston. 5. Department of Physical Therapy, The University of Texas Medical Branch, Galveston. 6. Department of Internal Medicine, Division of Geriatrics, The University of Texas Medical Branch, Galveston.
Abstract
BACKGROUND: Physical function declines during hospitalization in geriatric patients, increasing the risk of loss of independence. There is a need for evidence-based, pragmatic interventions to improve functional recovery of older adults following acute hospitalization. Here, we report the results of a Phase I randomized clinical trial designed to determine safety and effect size of protein supplementation, exercise, and testosterone interventions on 30-day post-discharge functional recovery and readmissions in geriatric patients. METHODS: A total of 100 patients admitted to the University of Texas Medical Branch hospital for an acute medical illness were randomized to one of five intervention groups: isocaloric placebo, whey protein supplement, in-home rehabilitation + placebo, in-home rehabilitation + whey protein, or testosterone. Primary outcome measure was the change from baseline in short physical performance battery score at 1 and 4 weeks post-discharge. Secondary outcomes were changes in body composition, activities of daily living, and 30-day readmissions. Comparisons were made across study groups and between placebo and all active intervention groups. RESULTS: Four weeks post-discharge, the short physical performance battery total score and balance score increased more in active intervention groups than placebo group (p < .05). There were no significant differences in change in body composition or activities of daily living across groups or between active intervention groups and placebo group. Readmission rates were highest in placebo (28%), followed by rehabilitation + placebo (15%), whey protein (12%), rehabilitation + whey protein (11%), and testosterone (5%). There was a trend for lower readmission rates in all active intervention groups (11%) versus placebo group (28%). CONCLUSIONS: Findings from this Phase I clinical trial suggest that pragmatic, evidence-based interventions may accelerate recovery from acute hospitalization in geriatric patients. These data provide essential information to design larger randomized controlled trials to test the effectiveness of these interventions.
RCT Entities:
BACKGROUND: Physical function declines during hospitalization in geriatric patients, increasing the risk of loss of independence. There is a need for evidence-based, pragmatic interventions to improve functional recovery of older adults following acute hospitalization. Here, we report the results of a Phase I randomized clinical trial designed to determine safety and effect size of protein supplementation, exercise, and testosterone interventions on 30-day post-discharge functional recovery and readmissions in geriatric patients. METHODS: A total of 100 patients admitted to the University of Texas Medical Branch hospital for an acute medical illness were randomized to one of five intervention groups: isocaloric placebo, whey protein supplement, in-home rehabilitation + placebo, in-home rehabilitation + whey protein, or testosterone. Primary outcome measure was the change from baseline in short physical performance battery score at 1 and 4 weeks post-discharge. Secondary outcomes were changes in body composition, activities of daily living, and 30-day readmissions. Comparisons were made across study groups and between placebo and all active intervention groups. RESULTS: Four weeks post-discharge, the short physical performance battery total score and balance score increased more in active intervention groups than placebo group (p < .05). There were no significant differences in change in body composition or activities of daily living across groups or between active intervention groups and placebo group. Readmission rates were highest in placebo (28%), followed by rehabilitation + placebo (15%), whey protein (12%), rehabilitation + whey protein (11%), and testosterone (5%). There was a trend for lower readmission rates in all active intervention groups (11%) versus placebo group (28%). CONCLUSIONS: Findings from this Phase I clinical trial suggest that pragmatic, evidence-based interventions may accelerate recovery from acute hospitalization in geriatric patients. These data provide essential information to design larger randomized controlled trials to test the effectiveness of these interventions.
Authors: P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; D A Lenrow; J H Holmes; A Dlewati; J Santanna; C J Rosen; B L Strom Journal: J Clin Endocrinol Metab Date: 1999-08 Impact factor: 5.958
Authors: C Wang; R S Swerdloff; A Iranmanesh; A Dobs; P J Snyder; G Cunningham; A M Matsumoto; T Weber; N Berman Journal: J Clin Endocrinol Metab Date: 2000-08 Impact factor: 5.958
Authors: Arny A Ferrando; Melinda Sheffield-Moore; Catherine W Yeckel; Charles Gilkison; Jie Jiang; Alison Achacosa; Steven A Lieberman; Kevin Tipton; Robert R Wolfe; Randall J Urban Journal: Am J Physiol Endocrinol Metab Date: 2002-03 Impact factor: 4.310
Authors: Douglas Paddon-Jones; Melinda Sheffield-Moore; Xiao-Jun Zhang; Elena Volpi; Steven E Wolf; Asle Aarsland; Arny A Ferrando; Robert R Wolfe Journal: Am J Physiol Endocrinol Metab Date: 2003-10-28 Impact factor: 4.310
Authors: Cathleen Colón-Emeric; Heather E Whitson; Sarah D Berry; Roger A Fielding; Denise K Houston; Douglas P Kiel; Clifford J Rosen; Kenneth L Seldeen; Elena Volpi; James P White; Bruce R Troen Journal: J Am Geriatr Soc Date: 2019-12-02 Impact factor: 5.562
Authors: Iñaki Echeverria; Maria Amasene; Miriam Urquiza; Idoia Labayen; Pilar Anaut; Ana Rodriguez-Larrad; Jon Irazusta; Ariadna Besga Journal: Int J Environ Res Public Health Date: 2020-01-20 Impact factor: 3.390